LinkedIn Logo
February 19-21 2019

30+ Expert Speakers ♦ 3 Days  2 Streams ♦ 3 Workshops ♦ 10+ Hours of Networking

27[1]

Robert Bell
Associate Research Fellow Rare Disease Research Unit
Pfizer

5[1]

Daniel Klamer
Vice President, Business Development and Scientific Strategy
Anavex

5[1]

Jonathan Brotchie
Co-founder & Chairman
Atuka

2[1]

C. Anthony Altar
Founder
NeuroDrug Consulting

6[1]

Lloyd Mitchell
Chief Executive Officer & Chief Scientific Officer
RetroTherapy

20[1]

Murali Gopalakrishnan
Senior Director, Global Head, Search & Evaluation Neuroscience
AbbVie

28[1]

Sophie Parmentier-Batteur
Director, Neuroscience Discovery
Merck

19[1]

Martin Tolar
Founder, 
President & Chief Executive Officer
Alzheon

2[1]

Stephen Wood
Director, 
Neuroscience Research
Amgen

11[1]

Jean-Philippe Courade
Director, Research Project Leader Neurodegeneration
UCB Biopharma

25[1]

Pablo Sardi
Director, Neuroscience Research & Development
Sanofi

14[1]

Fiona Elwood
Head, Neurodegeneration
Novartis

26[2]

Sean Smith
Executive Director, Neuroscience Research
Merck

7[1]

Diana Price
Senior Director, Neurosciences & In Vivo Pharmacology
Neuropore Therapies, Inc

30[1]

Spyros Papapetropoulos
Executive Vice President, Head of Research & Development& Chief Medical Officer
Cavion

9[1]

Diane Stephenson
Executive Director, Critical Path for Parkinson's
Critical Path Institute

6[1]

Cyrille Sur
Executive Director, Neuroscience Imaging Lead
Merck

21[1]

Nadeem Sarwar
Founder & President
Eisai Center for Genetics Guided Dementia Discovery

3[1]

Barbara Tate
Venture Partner
Dementia Discovery Fund

24[1]

Richard Ransohoff
Entrepreneur In Residence
Third Rock Ventures

4[1]

Chee Yeun Chung
Scientific Co-founder & Associate Director
Yumanity Therapeutics

1[2]

Tina Schwabe
Head, Immuno-Neurology
Alector

29[2]

Steven Braithwaite
Chief Scientific Officer
Alkahest

8[1]

Darren Baker
Assistant Professor
Mayo Clinic

23[1]

Nir Lipsman
Assistant Professor
University of Toronto

4[1]

Mathias Schmidt
Chief Executive Officer
ArmaGen

10[1]

Holly Soares
Head of Translational Neuroscience
AbbVie

3[1]

Tricia Thornton-Wells
Director of Clinical Biomarkers, Translational Medicine and Biomarkers
Vertex Pharmaceuticals

12[1]

Jesse Cedarbaum
Vice President, Neurology Early Clinical Development
Biogen

Untitled design (73)

Jonathan Levenson
Vice President, Preclinical Research and Development
Proclara BioSciences

13[1]

Johan Luthman
Vice President, Neuroscience Clinical Development
Eisai

22[1]

Michele Vendruscolo
Professor, Centre for Misfolding Diseases
University of Cambridge